Safety and Efficacy of Recombinant Botulinum Toxin Type A for Moderate-to-severe Glabellar Lines: A Multicenter Randomized Controlled Trial
- DOI
- 10.1097/prs.0000000000012960
- Published
- 2026-02-23
- Container
- Plastic & Reconstructive Surgery
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/prs.0000000000012960,
title = {Safety and Efficacy of Recombinant Botulinum Toxin Type A for Moderate-to-severe Glabellar Lines: A Multicenter Randomized Controlled Trial},
author = {Qingfeng Li and Xiao Long and Chongyuan Xu and Zhiqi Hu and Yun Xie and Nanze Yu and Ping Jiang and Wu Yang and Xiaoyun Sun},
year = {2026},
journal = {Plastic \& Reconstructive Surgery},
doi = {10.1097/prs.0000000000012960},
url = {https://doi.org/10.1097/prs.0000000000012960}
}RIS
TY - JOUR TI - Safety and Efficacy of Recombinant Botulinum Toxin Type A for Moderate-to-severe Glabellar Lines: A Multicenter Randomized Controlled Trial AU - Qingfeng Li AU - Xiao Long AU - Chongyuan Xu AU - Zhiqi Hu AU - Yun Xie AU - Nanze Yu AU - Ping Jiang AU - Wu Yang AU - Xiaoyun Sun PY - 2026 JO - Plastic & Reconstructive Surgery DO - 10.1097/prs.0000000000012960 UR - https://doi.org/10.1097/prs.0000000000012960 ER -
APA
Li, Q., Long, X., Xu, C., Hu, Z., Xie, Y., Yu, N., Jiang, P., Yang, W., & Sun, X. (2026). Safety and Efficacy of Recombinant Botulinum Toxin Type A for Moderate-to-severe Glabellar Lines: A Multicenter Randomized Controlled Trial. Plastic & Reconstructive Surgery. https://doi.org/10.1097/prs.0000000000012960
Source records
- crossref · retrieved 2026-09-27T13:22:44.672Z